FibroBiologics

FBLGNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$9.055 M

$1.36 -4.89%

Close of 21 Sept 2026

Revenue

—

Not reported

Earnings

-$18.6M

Loss-making

Shares outstanding

6,658,193

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#437Aprea TherapeuticsAPRE$9.28M
#438BullFrog AIBFRG$9.14M
#439FibroBiologicsFBLG$9.06M
#440ExicureXCUR$8.25M
#441Ensysce BiosciencesENSC$8.19M

What if FibroBiologics were worth as much as…

Open the what-if tool →

Gold $30.3T

$4,546,888

Per share 3,343,300× higher

Bitcoin $1.72T

$258,298.88

Per share 189,926× higher

Nvidia $5.48T

$823,024.85

Per share 605,165× higher

Or at a round number

$20.0M $50.0M $100.0M $200.0M

Where these numbers come from

Share counts and financials for FibroBiologics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.